According to data from Benzinga Pro, during Q4, NeuroOne Medical Tech's NMTC reported sales totaled $68 thousand. Despite a 50.2% increase in earnings, the company posted a loss of $1.37 million.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results